Trial
NCT01221740
Pain Assessment and Quality of Life in Back Pain Patients: Role of Milnacipran
Phase IIIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
Brigham and Women's Hospital
Collaborators
Forest Laboratories
Condition
Back Pain
Intervention
Savella
Why stopped
Company decided to discontinue
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2017-01-12